论文信息 - Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial - 字舞流文

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial

B. Clotet | C. Katlama | M. Johnson | A. Lazzarin | T. Campbell | M. Peeters | J. Vingerhoets | G. Smedt | W. Towner | R. Sinha | B. Baeten | B. Trottier | B. Woodfall | G. Beets | A. Moll